More on BLRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.82 |
|
|||
| Open | $2.84 | ||||
| 52 Wk High | $1.63 | ||||
| 52 Wk Low | $0.71 | ||||
| Day High | $2.91 | ||||
| Day Low | $2.81 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 16,045 | ||||
- BioLineRx and Hemispherian to present GLIX1 ovarian cancer data at ESMO
- BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026
- Form 6-K BioLineRx Ltd. For: Jul 08
- BioLineRx and Hemispherian report GLIX1 and olaparib synergy in ovarian cancer
- BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model
- BioLineRx (BLRX) Reports In-Line Q1 EPS
- Form 6-K BioLineRx Ltd. For: May 27
- BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
- BioLineRx and Hemispherian to present GLIX1 data at ASCO 2026
- Form 6-K BioLineRx Ltd. For: May 22
Entities mentioned with BLRX
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- H.C. Wainwright | View Related Stories »
- PDUFA | View Related Stories »
- Roth Capital | View Related Stories »
- Show More...
